Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

LG Life Sciences Ltd. engages in the development, production and marketing medicine and fine chemicals. Its products include growth hormone products, arthritis medicine, diabetes medicine, cosmetic surgery products, hypertension treatment, synthetic medicinal raw materials, and pesticide raw material. The company was founded on August 1, 2002 and is headquartered in Seoul, South Korea.

Lunan Pharmaceutical Group is an Integrated pharmaceutical group, National innovative enterprise and National torch plan key high-tech enterprise that produces, researches and sells both traditional Chinese medicine, chemical medicine and bio-pharmaceutical medicinal products.

Part of Lunan Pharmaceutical Group Co., Ltd., Shandong New Time Pharmaceutical Co. Ltd. is a Chinese company located in Linyi that manufactures pharmaceutical products.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Merck Canada, Inc., part of Merck & Co., Inc., is a company headquartered in Kirkland, QC, Canada. The firm manufactures prescription medicines, vaccines, biologic therapies and animal health products. Marwan Akar is the CEO, in this role since 1997.\nThe company says this about itself: For more than 125 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world.

Laurus labs is an innovation-driven¸ people-centric & client-focused organization offering a broad and integrated portfolio of products & services to the global pharmaceutical industry. Equipped with a world-class infrastructure manned by best-in-class personnel & driven by the core values of knowledge, innovation and excellence, within a relatively short period, Laurus labs emerged as a segment-leading manufacturer of high quality APIs, a preferred partner for NCE development & manufacture & a trusted source of specialty ingredients for the nutraceutical industry. Given the strengths, capabilities & experience, Laurus Labs is uniquely positioned to help its clients in their endeavor of ‘quicker to market’ & thus contributing towards improving access to quality & affordable healthcare worldwide.

Perrigo API Ltd. develops and markets active pharmaceutical ingredients. The company was founded in 1987 and is headquartered in Bnei Brak, Israel.

Formosa Laboratories, Inc. produces APIs and UV-filters in its modern facilities near Taipei. Its GMP compliance has been approved by DOH of Taiwan, US FDA, BGV of Germany, EDQM and PMDA of Japan. Formosa’s major API products include Vitamin D derivatives (Alfacalcidol, Calcitriol, Calcipotriol, Doxercalciferol, and Paricalcitol), Balsalazide, Benzonatate, Capsaicin, Colesevelam, Gadodiamide, Flupentixol, Melitracen, Meprobamate, Montelukast, Mycophenolate Mofetil, Sevelamer (HCl and Carbonate), and Taltirelin. As a major producer in the world, our UV-filter products include avobenzone and Octinoxate. We also provide custom synthesis service from process development to full commercial production for APIs and other specialty chemicals, with full documentation support.

Jinan New Times Pharmaceutical Technology Co., Ltd., established on 2015-10-16, Business scope includes traditional Chinese medicine,Technology Development of Health Food,technology transfer,technical consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ.

DONGKOOK Pharm. Co. Ltd. constructed the prefilled syringe system in its second factory (located at Kwanghyewon-myeon, Jincheon-gun, Chungbuk) for the first time in Asia and produced a large amount of various kinds of ultramodern injection agents. Located on its site are its central research institute, raw material factory, etc. where the raw materials of its main products are extracted and synthesized directly. Also, its third factory completed in 1994 is equipped with ultramodern facilities and is by no means inferior to other factories as the base of a leading company in a new millennium. Particularly, DONGKOOK invests more than 5% of the annual sale for research and development expenses while operating its central research institute centered on holders of master’s degree and PhD.

Since the establishment of Sunkyung Textiles in 1969, SK Chemicals has grown through continuous change and innovation into a chemical and life sciences enterprise representing South Korea. SK Chemicals’ new mission statement says, "They enhance human health and protect the Earth’s environment" and they have reorganized their business structure to focus on the two large sectors of green chemicals and life sciences. Providing distinguished chemical and life sciences products and solutions based on the world's highest technology standards, SK Chemicals is recognized as a leading global company of environmentally-friendly materials and total healthcare solutions. Their green chemical business is steadily progressing as a leading global company in the environmentally-friendly materials business by using the world’s best technology, knowledge, and production facilities. To achieve this goal, SK Chemicals has selected four new core areas of business: bio-materials, composites, high-performance materials, and energy saving materials while continuing a commitment to R&D activities.

R.P. Scherer Technologies LLC, a subsidiary of Catalent, Inc., is an American company that develops, manufactures and sells oral, topical, sterile and inhaled forms of drug delivery products.

Inke SA, part of Permira I.P. Ltd., is a Spanish company located in Barcelona. The firm manufactures active pharmaceutical ingredients. It was founded in 1980.\nThe company says this about itself: Inke is a leading global manufacturer of inhalation active pharmaceutical ingredients (APIs) established in 1980 and based in Castellbisbal (Barcelona, Spain). With more than 25 years of experience in respiratory APIs, the company focuses on the development and manufacturing of high–added-value active substances for the pharmaceutical industry for use in inhalation therapies. The company holds great expertise for the treatment of respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD). This qualifies Inke to be a key supplier to major generic and branded companies worldwide, having twelve respiratory APIs for inhalation in its portfolio and distributing its products to more than 40 countries including Europe, the US, Japan, Korea, China and Turkey. Inke has been successfully inspected by every major global authority, including the US-FDA since 2002 (latest inspection in March 2023). It is fully EU-GMP compliant and holds ISO 9001 and ISO 14001 certifications. The company has a strong regulatory track-record with 10 Certificates of Suitability (CEPs), 26 EU-DMF, 21 US-DMF, 8 JP-DMF, 11 KR-DMF and 9 CN-DMF.

Mudanjiang Hengyuan Pharmaceutical Co., Ltd., established on 2004-03-03, The scope of business includes the production of raw materials(montelukast sodium,Mesalazine,bezafibrate,Clopidogrel bisulfate);drug development;Import and export of goods and technology(law,Items prohibited and restricted by laws and regulations can only be operated after obtaining approval and permit).

Tianjin Hanrui Pharmaceutical Co., Ltd., established on 2010-01-19, Business scope includes licensed projects:pharmaceutical production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Information Consulting Service(Not including licensing information consulting services);Unit logistics management service;Chemical product sales(No licensed chemical products);Non-residential real estate leases;business management.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Beijing Hanmei Pharmaceutical Co., Ltd., established on 1996-03-27, The scope of business includes the production of pharmaceuticals(Excluding country restrictions and licensed products),Healthy food,health drink,cosmetic;sell food;Wholesale Health Food;Sell ​​self-produced products,cosmetic,hygiene products,daily necessities,Class Ι medical device,Disinfectant;business inquiries;Technical extension services;technology development,technology transfer,Technical Services,technical consulting;Wholesale machinery and equipment,Mechanical equipment parts;Import and export;Technology Import and Export;Agent import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Except for projects restricted by the state and without special approval.Sale of food and items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)